Skip to content
A Potential New Approach to Treating Addiction

GLP-1 (Glucagon-like peptide-1 receptor agonists), originally developed for type 2 diabetes and obesity, are now being explored for their potential to treat substance use disorders (SUD). Early research suggests these medications could help curb addictive behaviors, opening much needed novel treatment approaches for addiction.  What is GLP-1? GLP-1 is a hormone that helps regulate blood … Continued

Read More